Why is this medication prescribed?

Eptinezumab-jjmr injection is prescribed for the preventive treatment of migraine in adults. It belongs to a class of medications called monoclonal antibodies, which work by targeting and inhibiting the activity of a protein called calcitonin gene-related peptide (CGRP), which is believed to play a key role in migraine attacks.

How should this medicine be used?

The dosage and administration of eptinezumab-jjmr injection may vary depending on individual patient factors and healthcare provider recommendations. It is administered by a healthcare professional in a clinical setting, usually as a 30-minute intravenous infusion. The recommended dose is 100 mg every 3 months.

It’s important to follow the dosage and administration instructions provided by your healthcare provider to ensure the medication’s effectiveness and safety. If you have any questions or concerns about the use of eptinezumab-jjmr injection, it’s essential to discuss them with your healthcare provider

Other uses for this medicine

Eptinezumab-jjmr injection is primarily indicated for the preventive treatment of migraine headaches and is not approved for other uses. However, it’s essential to note that healthcare providers may sometimes prescribe medications for off-label uses based on their clinical judgment and the patient’s specific needs.

What special precautions should I follow?

Regarding special precautions for eptinezumab-jjmr injection, there are several considerations:

• Allergic reactions: Patients should be monitored for signs of allergic reactions during and after the infusion. Symptoms of an allergic reaction may include rash, itching, swelling, dizziness, difficulty breathing, or chest tightness. If any of these symptoms occur, medical attention should be sought immediately.
• Infections: Eptinezumab-jjmr injection may increase the risk of infections. Patients should be advised to report any signs or symptoms of infection to their healthcare provider promptly. It’s important to avoid eptinezumab-jjmr injection in patients with an active infection.
• Hypersensitivity: Patients with a known hypersensitivity or allergy to eptinezumab-jjmr or any of its components should not receive the medication.
• Pregnancy and breastfeeding: The safety of eptinezumab-jjmr injection during pregnancy and breastfeeding has not been established. Pregnant or breastfeeding individuals should discuss the potential risks and benefits with their healthcare provider before using this medication.
• Immunogenicity: As with any biologic medication, patients may develop antibodies against eptinezumab-jjmr, which could affect its effectiveness or lead to adverse reactions. Healthcare providers should monitor patients for signs of immunogenicity.
• Other medications: Patients should inform their healthcare provider about all medications, supplements, and herbal products they are taking, as eptinezumab-jjmr injection may interact with other drugs.
• Hepatic impairment: No dosage adjustment is required for patients with mild to moderate hepatic impairment. However, eptinezumab-jjmr injection has not been studied in patients with severe hepatic impairment, so caution is advised in this population.

As with any medication, it’s crucial to follow the instructions provided by your healthcare provider and to report any unusual or concerning symptoms promptly. If you have any questions or concerns about eptinezumab-jjmr injection or its use, don’t hesitate to discuss them with your healthcare provider.

What special dietary instructions should I follow?

Regarding special dietary instructions, there are no specific dietary restrictions associated with Eptinezumab-jjmr Injection. However, it’s always advisable to maintain a balanced diet and stay hydrated, especially during treatment for migraines.

What should I do if I forget a dose?

If you forget a dose of Eptinezumab-jjmr Injection, contact your healthcare provider to determine the best course of action. It’s crucial not to double the dose to make up for a missed one, as this could increase the risk of adverse effects. Follow your healthcare provider’s instructions closely to ensure optimal treatment outcomes.

What side effects can this medication cause?

Like all medications, Eptinezumab-jjmr Injection may cause side effects, although not everyone experiences them. Common side effects associated with Eptinezumab-jjmr Injection may include:

• Hypersensitivity reactions: These may include rash, itching, swelling, dizziness, difficulty breathing, or chest tightness. Seek immediate medical attention if you experience any signs of a severe allergic reaction.
• Infections: Eptinezumab-jjmr Injection may increase the risk of infections, including upper respiratory tract infections and urinary tract infections.
• Injection site reactions: These can include pain, redness, swelling, or itching at the injection site.
• Hypertension (high blood pressure): Some patients may experience an increase in blood pressure while receiving Eptinezumab-jjmr Injection.
• Fatigue: Feeling tired or fatigued is a common side effect reported by some individuals receiving Eptinezumab-jjmr Injection.
• Nausea: Some patients may experience nausea as a side effect of Eptinezumab-jjmr Injection.
• Muscle spasms: Muscle spasms or cramps may occur in some individuals receiving Eptinezumab-jjmr Injection.
• Dizziness: Feeling dizzy or lightheaded is another potential side effect reported by some patients.

It’s important to note that the above list is not exhaustive, and other side effects may occur. Additionally, individual responses to medication can vary, so not everyone will experience the same side effects. If you experience any concerning or persistent side effects while receiving Eptinezumab-jjmr Injection, notify your healthcare provider promptly. They can provide guidance and determine whether any adjustments to your treatment plan are necessary.

What should I know about storage and disposal of this medication?

Storage and Disposal of Eptinezumab-jjmr Injection:

• Storage:
  • Eptinezumab-jjmr Injection should be stored in the refrigerator at a temperature of 36°F to 46°F (2°C to 8°C).
  • Do not freeze Eptinezumab-jjmr Injection.
  • Keep the medication in its original carton to protect it from light.
  • Do not shake the vial or use the medication if it appears discolored or contains particles.
• Disposal:
  • Dispose of any unused or expired Eptinezumab-jjmr Injection properly according to local regulations or as instructed by your healthcare provider or pharmacist.
  • Do not dispose of medications in household trash or wastewater unless instructed to do so.

In case of emergency/overdose

• In case of an emergency or overdose, such as receiving too much of the medication accidentally, seek immediate medical attention or contact a poison control center.
• The symptoms of an overdose with Eptinezumab-jjmr Injection are not well-established. Nevertheless, it’s essential to seek medical assistance promptly if you suspect an overdose.

What other information should I know?

• Eptinezumab-jjmr Injection is intended for intravenous use only and should be administered by a healthcare professional in a clinical setting.
• Inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting Eptinezumab-jjmr Injection to prevent potential drug interactions.
• Attend all scheduled appointments for Eptinezumab-jjmr Injection infusions as recommended by your healthcare provider.
• Report any new or worsening symptoms to your healthcare provider, especially if you experience allergic reactions, infections, or any other concerning side effects.
• Keep Eptinezumab-jjmr Injection out of reach of children and pets.

Following these guidelines ensures the safe and effective use of Eptinezumab-jjmr Injection. If you have any questions or concerns about storage, disposal, or emergency procedures, consult your healthcare provider or pharmacist for further clarification.